Metal-Based Drugs

Metal-Based Drugs / 1997 / Article

Open Access

Volume 4 |Article ID 431870 |

Weiping Liu, Huizhou Xiong, Yikun Yang, Ling Li, Zhiqiang Shen, Zhihe Chen, "Antitumor Activity of the Carboplatin-α-Cyclodextrin Adduct", Metal-Based Drugs, vol. 4, Article ID 431870, 2 pages, 1997.

Antitumor Activity of the Carboplatin-α-Cyclodextrin Adduct

Received19 Aug 1997
Accepted11 Sep 1997


Antitumor activity of the adduct between Carboplatin and α-cyclodextrin has been tested against Sarcoma 180 (S180) and Ehrlich ascites carcinoma (EAC) murine tumors. The preliminary toxicity has also been evaluated by histological examinations of the treated animals. The results show the adduct has less antitumor efficacy than and similar toxicity to Carboplatin.

Copyright © 1997 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Order printed copiesOrder

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.